Tag: Cochlear Limited
Cochlear hits $893m in sales revenue with clinical demand for hearing aids, implants
Medical device company Cochlear Limited has shared its revenue for the six months through December of $885.2 million, a nine per cent increase driven by strong growth in cochlear and acoustic implant sales.
Cochlear buys hearing implant maker Oticon for A$170m
Cochlear Limited, a global leader in implantable hearing solutions, has agreed to acquire Oticon Medical for approximately A$170 million.
The announcement comes after Oticon's parent...
LBT Innovations names new CEO
Australian developer of clinical and diagnostic technology LBT Innovations announced that Senior Cochlear Limited executive, Mr Brent Barnes, has been appointed as the company’s...
Cochlear announces European product launch
Cochlear Limited has announced that it will be launching the Cochlear Nucleus Profile Series across Europe this month.
The global implantable hearing solutions developer has...
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
